ES2128358T3 - Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis. - Google Patents

Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis.

Info

Publication number
ES2128358T3
ES2128358T3 ES92921587T ES92921587T ES2128358T3 ES 2128358 T3 ES2128358 T3 ES 2128358T3 ES 92921587 T ES92921587 T ES 92921587T ES 92921587 T ES92921587 T ES 92921587T ES 2128358 T3 ES2128358 T3 ES 2128358T3
Authority
ES
Spain
Prior art keywords
neisseria meningitidis
isolated human
vaccine including
subunit
transferrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921587T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Application granted granted Critical
Publication of ES2128358T3 publication Critical patent/ES2128358T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA SUBUNIDAD DE MENOR PESO MOLECULAR DEL RECEPTOR DE LA TRANSFERRINA HUMANA DE UNA CEPA DE N.MENINGITIDIS, EN FORMA PURIFICADA ASI COMO UNA COMPOSICION FARMACEUTICA DE VACUNA DESTINADA A LA PREVENCION O A LA ATENUACION DE LOS EFECTOS DE UNA INFECCION DE N.MENINGITIDIS QUE CONTIENE DICHA SUBUNIDAD EN FORMA PURIFICADA.
ES92921587T 1991-10-03 1992-09-29 Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis. Expired - Lifetime ES2128358T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.

Publications (1)

Publication Number Publication Date
ES2128358T3 true ES2128358T3 (es) 1999-05-16

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921587T Expired - Lifetime ES2128358T3 (es) 1991-10-03 1992-09-29 Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis.

Country Status (15)

Country Link
US (2) US5618540A (es)
EP (1) EP0560969B1 (es)
JP (1) JPH06503364A (es)
AT (1) ATE174930T1 (es)
AU (1) AU668522B2 (es)
CA (1) CA2096411A1 (es)
DE (1) DE69227984T2 (es)
DK (1) DK0560969T3 (es)
ES (1) ES2128358T3 (es)
FI (1) FI107262B (es)
FR (1) FR2682114B1 (es)
GR (1) GR3029580T3 (es)
HU (1) HU219762B (es)
NO (1) NO309865B1 (es)
WO (1) WO1993007172A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
DK0678034T3 (da) * 1993-01-11 1999-11-08 Dana Farber Cancer Inst Inc Induktion af cytotoksiske T-lymfocytreaktioner
CA2175332C (en) * 1993-11-08 2009-04-07 Sheena M. Loosmore Haemophilus transferrin receptor genes
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
EP1144643A1 (en) 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
CA2761924C (fr) 2009-05-14 2017-10-31 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
CN102596240B (zh) * 2009-08-27 2015-02-04 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
ES2912751T3 (es) 2013-12-02 2022-05-27 Eng Antigens Inc Composiciones inmunogénicas y vacunas derivadas de proteínas receptoras de superficie bacteriana

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
ES2329979T3 (es) * 1990-08-23 2009-12-03 The University Of North Carolina At Chapel Hill Proteinas de union de transferencia de neisseria gonorrhoeae y neisseria meningitis. su uso como vacuna.
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
NO309865B1 (no) 2001-04-09
FI932490L (fi) 1993-06-01
ATE174930T1 (de) 1999-01-15
DK0560969T3 (da) 1999-08-23
FR2682114B1 (fr) 1996-02-23
AU668522B2 (en) 1996-05-09
CA2096411A1 (en) 1993-04-04
US5928650A (en) 1999-07-27
FI107262B (fi) 2001-06-29
FI932490A0 (fi) 1993-06-01
HU219762B (hu) 2001-07-30
NO932009L (no) 1993-07-20
EP0560969B1 (fr) 1998-12-23
DE69227984T2 (de) 1999-05-12
JPH06503364A (ja) 1994-04-14
FR2682114A1 (fr) 1993-04-09
GR3029580T3 (en) 1999-06-30
DE69227984D1 (de) 1999-02-04
US5618540A (en) 1997-04-08
WO1993007172A1 (fr) 1993-04-15
NO932009D0 (no) 1993-06-02
HU9301631D0 (en) 1993-10-28
EP0560969A1 (fr) 1993-09-22
AU2764092A (en) 1993-05-03
HUT69929A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
ES2090696T3 (es) Vacunas contra infecciones de neisseria meningitidis.
ES2096639T3 (es) Derivados de benzofurano, benzotiofeno, indol o indolizina, su procedimiento de preparacion, asi como las composiciones que los contienen.
ES2128358T3 (es) Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis.
DK0833619T3 (da) Styret frigivelse af lægemidler indgivet ved sublingual eller bukkal administration
CY1118606T1 (el) Πολυπεπτιδικα εμβολια για ευρεια παραγωγη εναντι υπερμολυσματικων μηνιγγιοκοκκιkων σειρων
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2192582T3 (es) Composicion de vaccineo, conteniendo quitina, parcialmente deacetilado.
EA200300827A1 (ru) Поливалентная менингококковая полисахаридно-белковая конъюгированная вакцина
CY1111325T1 (el) Πολυεπιτοπικη πρωτεϊνη-φορεας
CO5640082A2 (es) Compuestos derivados de succinimida heterociclicos fusionados que son moduladores de la funcion del receptor de la hormona nuclear y composiciones farmaceuticas que los contienen
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
ES8500997A1 (es) Un metodo para producir un peptido.
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
DE69122266D1 (de) Antivirale verbindungen
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
ATE248601T1 (de) Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
ATE201601T1 (de) Pharmazeutische zusammensetzungen enthaltend ein neutralisiertes virus, und verwendung derselben
ES2170177T3 (es) Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
ES2081097T3 (es) Vacuna contra los nematodos.
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
SG163571A1 (en) Rotavirus vaccine inducing heterotypic cross protection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 560969

Country of ref document: ES